‘People want vanilla ice cream’: 23andMe CEO Anne Wojcicki grapples with company’s dual identity

SAN FRANCISCO — 23andMe CEO Anne Wojcicki said she’s “open to all ideas” in addressing investor confusion and turning around a disappointing start to the genomic pioneer’s life as a public company.

Even as the JP Morgan Healthcare Conference brought a burst of optimism to start 2024, stoked…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks